Skip to main content
. 2019 Jan 18;37(10):770–779. doi: 10.1200/JCO.18.00822

FIG A3.

FIG A3.

Disease-free survival of patients with low hypodiploidy (A) and near haploidy (B) who received chemotherapy only or underwent hematopoietic cell transplantation. The 5- and 8-year estimates are shown on the curves. Curves originate at a landmark of 153 days (median time from complete remission to transplantation) to adjust for bias related to early events and account for delayed entry of patients into the transplantation group. The first set of No. at risk is at 0.42 years (153 days) since complete remission for both panels A and B.